Showing results (341-350 of 409) with videos related to
Sort By:
Pageof 41
Molecular Therapy. Oncology|October 13, 2025
CXCL10-induced chemotaxis of ex vivo-expanded natural killer cells combined with NKTR-255 enhances anti-tumor efficacy in osteosarcomaShiori Eguchi, Wen Luo, Hongwen Zhu, et al.Molecular Therapy. Oncology|September 16, 2025
Perturbed CD81 in lung-cancer-derived extracellular vesicles modifies its function in cancer pathophysiologyAnjugam Paramanantham, Siddharth Das, Rahmat Asfiya, et al.Molecular Therapy. Oncology|April 28, 2025
Cost-effective strategies for CAR-T cell therapy manufacturingLuiza Abdo, Leonardo Ribeiro Batista-Silva, Martín Hernán BonaminoMolecular Therapy. Oncology|October 27, 2025
Installation of dominant-negative mutations in FAS and TGFβR2 via base editing in primary T cellsBryce J Wick, Mitchell G Kluesner, Nicholas J Slipek, et al.Molecular Therapy. Oncology|October 27, 2025
Identifying gene expression signatures of oncolytic virus response in patient-derived pancreatic ductal adenocarcinoma organoidsMarco Huberts, Elham Aida Farshadi, Farzana Mohammad, et al.Molecular Therapy. Oncology|October 27, 2025
Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemiaAndrea López, David Charbonnier, Paula Vela, et al.Molecular Therapy. Oncology|October 2, 2025
Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic cancer cellsDebasmita Dutta, Sunil P Upadhyay, Archana De, et al.Molecular Therapy. Oncology|September 29, 2025
Targeting BCMA in multiple myeloma: A comprehensive review of immunotherapeutic strategies and clinical outcomesChi Ho Chan, Xin Yang, Minchuan Lyu, et al.Molecular Therapy. Oncology|October 2, 2025
Erratum: Ovatodiolide triggers ferroptosis in high-grade serous ovarian cancer through HMOX1 upregulationYew-Min Tzeng, Aye Aye Khine, Hsuan-Shun Huang, et al.Molecular Therapy. Oncology|October 6, 2025
Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapyAlexander Renner, Maximiliane S C Finkbeiner, Ferdinand V Haas, et al.Pageof 41